Inhalation particles
OwnerWiwik Watanabe, Petri Ahonen +5inventors
InventorsWiwik Watanabe, Petri Ahonen, Esko Kaupinnen, David Brown, Jorma Jokiniemi, Jorma Jokiniemi, Esa Muttonen
Life of this patent
Estimating the term…
Loading patent…
OwnerWiwik Watanabe, Petri Ahonen +5inventors
InventorsWiwik Watanabe, Petri Ahonen, Esko Kaupinnen, David Brown, Jorma Jokiniemi, Jorma Jokiniemi, Esa Muttonen
Estimating the term…
A method for preparing particles suitable for pulmonary drug delivery by inhalation, and inhalation compositions comprising such particles are provided. The method comprises providing a liquid feed stock comprising one or several active agents, atomising the liquid feed stock, suspending the droplets in a carrier gas, and passing the carrier gas and droplets through a heated tube flow reactor under predetermined residence time and temperature history, and collecting the particles produced. Fine uniform crystalline spherical uncharged particles with narrow aerodynamic particle size distribution between about 1 to 5 μm and rough surfaces, are obtained. The particles show improved dispersibility and stability.
A method for preparing particles suitable for pulmonary drug delivery, comprising the steps of:
Particles suitable for use in pulmonary drug delivery by inhalation, which particles are spherical and crystalline and incorporate one or several active agents, provided that the active agent is not ciclosporin.
Particles suitable for use in pulmonary drug delivery by inhalation, which particles are spherical and crystalline and incorporate one or several active agents, wherein the active agent is selected from a group consisting of a bronchodilator, steroidal anti-inflammatory agent, anti-allergic agent, expectorant, mucolytic agent, antihistamine, cyclooxygenase inhibitor, leukotriene synthesis inhibitor, leukotriene antagonist, PLA2 inhibitor, PAF antagonist or a combination thereof.
Particles suitable for use in pulmonary drug delivery by inhalation, which particles are spherical and crystalline and incorporate one or several active agents, wherein the active agent is selected from a group consisting of an antiarrhythmic agent, tranquilizer, cardiac glycoside, hormone, antihypertensive agent, antidiabetic agent, anticancer agent, sedative, analgesic agent, antibiotic, antifungal agent, vaccine, antiviral agent, vitamin or a combination thereof.
Dependencies are inferred from the claim text.